Vaccine-associated paralytic poliomyelitis in India during 1999: Decreased risk despite massive use of oral polio vaccine

Bulletin of the World Health Organization

Volumn 80, Issue 3, 2002, Pages 210-216

  Kohler, Kathryn A ^a   Banerjee, Kaushik ^a   Hlady, W Gary ^a   Andrus, Jon K ^a   Sutter, Roland W ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

India (source: MeSH, NLM); Oral adverse effects administration and dosage; Paralysis epidemiology; Poliomyelitis chemically induced epidemiology; Poliovirus vaccine; Poliovirus isolation and purification; Risk assessment

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

DISEASE CONTROL; HEALTH RISK; POLIOMYELITIS; RISK FACTOR; VACCINATION;

ARTICLE; FEMALE; HEALTH SURVEY; HUMAN; INDIA; INFANT; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; PARALYSIS; POLIOMYELITIS; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; VACCINATION; VIRUS TRANSMISSION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INDIA; INFANT; INFANT, NEWBORN; MALE; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; POPULATION SURVEILLANCE; RISK ASSESSMENT;

INDIA;

EID: 0036204143     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Polio eradication in the World Health Organization South-East Asia Region by the year 2000: Midway assessment of progress and future challenges
2. Paralytic poliomyelitis in England and Wales, 1985-91
3. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease
4. Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984
5. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91
6. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine: A risk factor for vaccine-associated paralytic poliomyelitis
7. Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection
8. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries
9. Poliomyelitis surveillance: The model used in India for polio eradication
10. Progress toward polio eradication - India 1998
11. Status of the global laboratory network for poliomyelitis eradication 1994-1996
12. Enteroviruses
13. Cellular receptor for poliovirus: Molecular cloning, 31ynucleotide sequence, and expression of a new member of the immunoglobulin superfamily
14. Oligonucleotide probes for the specific detection of wild poliovirus type 1 and type 3 endemic to Brazil
15. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase
16. Conquering polio in India
17. Outbreaks of paralytic poliomyelitis, 1976-1995
18. Combined immunization of infants with oral and inactivated poliovirus vaccines: Results of a randomized trial in the Gambia, Oman, and Thailand
19. Factors affecting the immunogenicity of oral poliovirus vaccine: A prospective evaluation in Brazil and the Gambia